Cardio Diagnostics Holdings, Inc., a Delaware-based company, filed a Registration Statement on Form S-8 with the Securities and Exchange Commission (SEC) on April 26, 2024. The purpose of the filing is to register an additional 1,060,458 shares of common stock for the Cardio Diagnostics Holdings, Inc. 2022 Equity Incentive Plan. This move follows the previous registration of 3,265,516 shares under the same plan on March 22, 2023. The newly registered shares are of the same class as those previously registered. The company's Annual Report for the fiscal year ended December 31, 2023, is incorporated by reference into this Registration Statement. Cardio Diagnostics Holdings has also undertaken to file post-effective amendments during the offering period to reflect any material changes.

Cardio Diagnostics Holdings, Inc., a Delaware-based company, filed a Registration Statement on Form S-8 with the Securities and Exchange Commission (SEC) on April 26, 2024. The purpose of the filing is to register an additional 1,060,458 shares of common stock for the Cardio Diagnostics Holdings, Inc. 2022 Equity Incentive Plan. This move follows the previous registration of 3,265,516 shares under the same plan on March 22, 2023. The newly registered shares are of the same class as those previously registered. The company's Annual Report for the fiscal year ended December 31, 2023, is incorporated by reference into this Registration Statement. Cardio Diagnostics Holdings has also undertaken to file post-effective amendments during the offering period to reflect any material changes.